A pandemic of coronavirus disease 2019 COVID-19 caused by severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 has been spreading throughout the world. Though molecular diagnostic tests are the gold standard for COVID-19 serological testing is emerging as a potential surveillance tool in addition to its complementary role in COVID-19 diagnostics. Indubitably quantitative serological testing provides greater advantages than qualitative tests but today there is still little known about serological diagnostics and what the most appropriate role quantitative tests might play. Diagnostic accuracy of an automated chemiluminescent immunoassay for anti-SARS-CoV-2 IgM and IgG antibodies: an Italian experience.